XML 116 R105.htm IDEA: XBRL DOCUMENT v3.19.2
Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 265 $ 94
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (13) (10)
Purchases of property and equipment (212) (295)
Proceeds from disposition of hospitals and other ancillary operations 161 88
Proceeds from sale of property and equipment 1 4
Purchases of available-for-sale securities and equity securities (39) (38)
Proceeds from sales of available-for-sale securities and equity securities 52 63
Increase in other investments (97) (53)
Net cash used in investing activities (147) (241)
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Deferred financing costs and other debt-related costs (28) (54)
Proceeds from noncontrolling investors in joint ventures 2 1
Redemption of noncontrolling investments in joint ventures (2) (6)
Distributions to noncontrolling investors in joint ventures (57) (52)
Borrowings under credit agreements 23 26
Issuance of long-term debt 2,034  
Proceeds from ABL facility 25 587
Repayments of long-term indebtedness (2,103) (709)
Net cash used in financing activities (107) (208)
Net change in cash and cash equivalents 11 (355)
Cash and cash equivalents at beginning of period 196 563
Cash and cash equivalents at end of period 207 208
Parent Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 4 37
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Changes in intercompany balances with affiliates, net (3) (36)
Net cash used in financing activities (4) (37)
Issuer [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities (67) (228)
Cash flows from investing activities:    
Proceeds from disposition of hospitals and other ancillary operations 18  
Net cash used in investing activities 18  
Cash flows from financing activities:    
Deferred financing costs and other debt-related costs (28) (54)
Changes in intercompany balances with affiliates, net 94 (186)
Issuance of long-term debt 2,034  
Proceeds from ABL facility 25 538
Repayments of long-term indebtedness (2,076) (70)
Net cash used in financing activities 49 228
Other Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 210 94
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (6) (3)
Purchases of property and equipment (176) (213)
Proceeds from disposition of hospitals and other ancillary operations 135 12
Proceeds from sale of property and equipment   1
Purchases of available-for-sale securities and equity securities (15) (25)
Proceeds from sales of available-for-sale securities and equity securities 25 50
Increase in other investments (63) (24)
Net cash used in investing activities (100) (202)
Cash flows from financing activities:    
Changes in intercompany balances with affiliates, net (82) 315
Borrowings under credit agreements 23 22
Proceeds from ABL facility   49
Repayments of long-term indebtedness (23) (636)
Net cash used in financing activities (82) (250)
Net change in cash and cash equivalents 28 (358)
Cash and cash equivalents at beginning of period 135 471
Cash and cash equivalents at end of period 163 113
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 118 191
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (7) (7)
Purchases of property and equipment (36) (82)
Proceeds from disposition of hospitals and other ancillary operations 8 76
Proceeds from sale of property and equipment 1 3
Purchases of available-for-sale securities and equity securities (24) (13)
Proceeds from sales of available-for-sale securities and equity securities 27 13
Increase in other investments (34) (29)
Net cash used in investing activities (65) (39)
Cash flows from financing activities:    
Proceeds from noncontrolling investors in joint ventures 2 1
Redemption of noncontrolling investments in joint ventures (2) (6)
Distributions to noncontrolling investors in joint ventures (57) (52)
Changes in intercompany balances with affiliates, net (9) (93)
Borrowings under credit agreements   4
Repayments of long-term indebtedness (4) (3)
Net cash used in financing activities (70) (149)
Net change in cash and cash equivalents (17) 3
Cash and cash equivalents at beginning of period 61 92
Cash and cash equivalents at end of period $ 44 $ 95